CAPTRUST FINANCIAL ADVISORS - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$43,495
+61.2%
50,000
+107.6%
0.00%
Q2 2023$26,976
+23.5%
24,086
+14.7%
0.00%
Q1 2023$21,846
+264.1%
21,006
+377.4%
0.00%
Q2 2022$6,0004,400
+4300.0%
0.00%
Q1 2022$01000.0%0.00%
Q4 2021$01000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders